Trump Medical Research Grant Lawsuit Settled
▼ Summary
– The ACLU and medical researchers reached a settlement requiring the NIH to restart reviews of grants previously blocked on ideological grounds by the Trump administration.
– The rejected grants will now go through the standard peer review process, though funding is not guaranteed.
– The Trump administration’s policy had rejected grants without review for topics it opposed, like climate change and DEI.
– This policy was later declared arbitrary and capricious, violating the Administrative Procedure Act, a decision upheld by the Supreme Court.
– Researchers sued over cancelled funding and blocked applications, leading to two overlapping legal cases.
A significant legal settlement has been reached concerning federal medical research grants that were previously blocked on ideological grounds during the previous administration. The American Civil Liberties Union, alongside other groups representing scientists, announced the agreement this week. While still pending final judicial approval, the settlement compels the National Institutes of Health to restart reviews for grants that were rejected without proper scientific evaluation. This does not automatically secure funding, but it ensures these proposals will finally undergo the standard peer review process, which is the cornerstone of objective scientific assessment.
The core of the dispute stemmed from a policy enacted shortly after the last presidential inauguration. Officials identified several broad and often vaguely defined research categories they would no longer support, including topics related to climate change, diversity initiatives, pandemic readiness, and gender studies. Federal agencies subsequently began canceling existing grants and blocking new applications that touched on these disfavored subjects. This led to the abrupt termination of studies ranging from antiviral drug development to investigations into prostate cancer rates within African American communities.
Researchers and their professional organizations filed lawsuits challenging these actions. The litigation eventually separated into two related cases: one focused on scientists who had active funding stripped away, and another addressing those whose grant applications were pulled from consideration before any review could occur. The courts ultimately ruled the administration’s policy arbitrary and capricious, a violation of the Administrative Procedure Act, a decision later affirmed by the Supreme Court. This legal foundation paved the way for the recent settlement, which seeks to rectify the disruption caused to the scientific enterprise and restore integrity to the grant-making system.
(Source: Ars Technica)
